Logo (Actavis) 855 (Guanfacine Hydrochloride Extended-Release 4 mg)
Pill with imprint Logo (Actavis) 855 is Yellow, Elliptical / Oval and has been identified as Guanfacine Hydrochloride Extended-Release 4 mg. It is supplied by Actavis Pharma, Inc..
Guanfacine is used in the treatment of adhd; high blood pressure and belongs to the drug class antiadrenergic agents, centrally acting. There is no proven risk in humans during pregnancy. Guanfacine 4 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo (Actavis) 855
Guanfacine Hydrochloride Extended-Release
- Imprint
- Logo (Actavis) 855
- Strength
- 4 mg
- Color
- Yellow
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, centrally acting
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Pharma, Inc.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00228-2855 | Actavis Pharma, Inc. |
| 42291-0327 | AvKare, Inc. |
More about guanfacine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 263 Reviews
- Drug class: antiadrenergic agents, centrally acting
- FDA Alerts (1)
Consumer resources
- Patient Information
- Guanfacine (Advanced Reading)
- Guanfacine Extended-Release Tablets
- Guanfacine Tablets
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.